Cipher Pharmaceuticals Inc.

TSX:CPH.TO

Drug Manufacturers - Specialty & Generic

Healthcare
$13.05 +0.94%

+$0.15 today

Market cap
$331.67M
Beta
0.48
P/E (TTM)
9.3
EPS (TTM)
$1.22
52W Low $11.98High $20.56

Volume 0.04M

Average 0.03M

CPH.TO Cash & Equivalents

Cash on hand and highly liquid investments that can be converted to cash almost immediately.

Cipher Pharmaceuticals Inc.TSX: CPH.TO

Cash & Equivalents · Q1 FY2026 · quarter ended Mar 2026

Cash & equivalents falls 70.8% from a year ago

Cash & equivalents stood at $6.41M at the end of Q1 FY2026, down 70.8% from a year earlier and down 14.2% from the prior quarter. Over 3 fiscal years it compounded at -36.2% a year.

Context

  • Cash & equivalents amounted to 4.2% of total assets at the end of Q1 FY2026, down 9.3 pp from a year earlier.
  • Cash & equivalents increased in 1 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether cash & equivalents keeps falling in the next quarterly balance sheet after a -70.8% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$6.41M-14.2% QoQ
Last fiscal yearDec 2025
$7.48M-58.1% YoY
Year agoMar 2025
$22M-70.8% since
Cash & Equivalents past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-70.8%——
1 year-58.1%——
3-year CAGR-36.2%——
5-year CAGR——
10-year CAGR——

Cash & Equivalents history

USD · from the balance sheet

Latest · FY2025
7.48M USD
Year-over-year change
-58.1%
4-year CAGR
-22.3%

Cash & Equivalents vs competitors

How CPH.TO compares with its peers on the latest reported figures

  • Peers report in different currencies, so cash & equivalents is compared through growth and share of total assets rather than absolute size.
  • Its year-over-year change of -70.8% is the lowest of 8, against a peer median of +33.8%.
  • Cash & equivalents amounts to 4.2% of total assets for CPH.TO, versus a peer median of 18.7%.
CPH.TO Competitors
Cash & Equivalents for CPH.TO and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
WEED.TOCanopy Growth CorporationMar 2026CA$364.68M CAD+220.4%-18.6%32.6%
ACB.TOAurora Cannabis Inc.Mar 2026CA$112.48M CAD-18.4%-28.0%18.7%
GUD.TOKnight Therapeutics Inc.Mar 2026CA$108.05M CAD-3.7%+2.2%9.9%
OGI.TOOrganiGram Holdings Inc.Mar 2026CA$53.94M CAD+309.2%—10.3%
FRX.TOFennec Pharmaceuticals Inc.Mar 2026$40.08M USD+76.7%+15.6%55.9%
TSND.TOTerrAscend Corp.Mar 2026$39.14M USD+33.8%+1.0%7.1%
CPH.TOCipher Pharmaceuticals Inc.Mar 2026$6.41M USD-70.8%-36.2%4.2%
EDT.TOSpectral Medical Inc.Mar 2026CA$1.92M CAD+14.9%-21.5%41.9%
Peer median (excluding CPH.TO) —+33.8%-8.8%18.7%

Competitors are the stored peer set for CPH.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents20.55M28.84M39.83M17.84M7.48M
Short-term Investments00000
Net Receivables6.66M6.8M5.09M13.86M11.19M
Inventory1.65M2.15M2.98M5.79M8.18M
Other Current Assets00378K01.16M
Total Current Assets29.33M38.16M48.27M38.48M28M
Property, Plant & Equipment (Net)501K481K402K680K567.96K
Goodwill15.71M15.71M15.71M17.45M17.42M
Intangible Assets3.65M2.75M1.76M78.75M71.88M
Long-term Investments19.85M18.94M000
Tax Assets2.47M16.67M19.89M26.76M38.12M
Other Non-current Assets(19.85M)(18.94M)19.89M386K235.57K
Total Non-current Assets22.32M35.62M37.76M124.03M128.22M
Total Assets51.65M73.78M86.03M162.51M156.22M
Account Payables5.56M4.11M4.64M5.87M6.38M
Short-term Debt00000
Tax Payables6.23M4.9M054K0
Deferred Revenue450K257K519K13.31M18.35M
Other Current Liabilities6.68M5.16M00(27.93K)
Total Current Liabilities12.29M9.37M5.25M19.87M25M
Long-term Debt00040M4.99M
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities00000
Total Non-current Liabilities460K327K259K40.3M5.21M
Total Liabilities12.75M9.7M5.51M60.17M30.2M
Common Stock18.12M17.72M18.01M27.68M27.81M
Retained Earnings25.2M50.52M66.27M77.65M99.93M
Accumulated OCI(9.51M)(9.51M)(9.51M)(9.51M)(9.5M)
Other Stockholders Equity00000
Minority Interest00000
Total Equity38.9M64.08M80.52M102.34M126.01M
Total Debt516K428K353K40.58M5.49M
Net Debt(20.03M)(28.41M)(39.47M)22.74M(1.98M)

Cipher Pharmaceuticals Inc.

TSX:CPH.TO

Intrinsic Alpha fair value

Locked

Current Price

$13.05

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.